Group One Trading’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $511K | Buy |
20,586
+16,074
| +356% | +$416K | 0.02% | 3325 |
|
|
2025
Q4 | $115K | Sell |
4,512
-4,529
| -50% | -$101K | ﹤0.01% | 4879 |
|
|
2025
Q3 | $146K | Buy |
+9,041
| New | +$146K | ﹤0.01% | 4987 |
|
|
2025
Q2 | – | Sell |
-24,771
| Closed | -$375K | – | 8852 |
|
|
2025
Q1 | $423K | Sell |
24,771
-59,937
| -71% | -$1.25M | 0.02% | 3269 |
|
|
2024
Q4 | $2.1M | Buy |
+84,708
| New | +$2.4M | 0.07% | 1868 |
|
|
2024
Q3 | – | Sell |
-59,007
| Closed | -$1.74M | – | 7447 |
|
|
2024
Q2 | $1.56M | Buy |
59,007
+27,099
| +85% | +$771K | 0.05% | 1643 |
|
|
2024
Q1 | $1.03M | Sell |
31,908
-105,599
| -77% | -$3.85M | 0.04% | 2058 |
|
|
2023
Q4 | $5.79M | Buy |
+137,507
| New | +$5.06M | 0.18% | 1028 |
|
|
2023
Q3 | – | Sell |
-75,991
| Closed | -$1.72M | – | 8493 |
|
|
2023
Q2 | $1.44M | Buy |
75,991
+52,135
| +219% | +$972K | 0.06% | 2013 |
|
|
2023
Q1 | $370K | Buy |
+23,856
| New | +$414K | 0.02% | 3040 |
|
|
2022
Q4 | – | Sell |
-57,027
| Closed | -$718K | – | 8089 |
|
|
2022
Q3 | $318K | Sell |
57,027
-6,020
| -10% | -$29.4K | 0.01% | 3676 |
|
|
2022
Q2 | $246K | Buy |
63,047
+5,937
| +10% | +$25.6K | 0.01% | 4107 |
|
|
2022
Q1 | $315K | Sell |
57,110
-27,184
| -32% | -$169K | 0.01% | 4321 |
|
|
2021
Q4 | $718K | Buy |
84,294
+4,482
| +6% | +$37K | 0.01% | 3698 |
|
|
2021
Q3 | $694K | Buy |
79,812
+48,544
| +155% | +$438K | 0.02% | 3826 |
|
|
2021
Q2 | $331K | Buy |
31,268
+21,642
| +225% | +$302K | 0.01% | 4681 |
|
|
2021
Q1 | $154K | Buy |
+9,626
| New | +$254K | ﹤0.01% | 5266 |
|
Other funds holding IMVT
DTC
BBA
TCM
VPM
VCM
